MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16229 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Haroon Taylor und 3 weiteren Autor:innen. Beteiligte Einrichtung: YewMaker, London, UK. Hauptthemen laut MEDLINE: Carbon Footprint. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SBRI Healthcare programme.
Abstract (Originalsprache)
Aims
Healthcare accounts for 5% of global greenhouse gas emissions, with medicines making a sizeable contribution. Product‐level medicine emission data is limited, hindering mitigation efforts. To address this, we created Medicine Carbon Footprint (MCF) Classifier, to estimate, standardize, stratify and visualize medicine carbon footprints.
Methods
We used molecular weight and chemical structure to estimate the process mass intensity and global warming potential of the active pharmaceutical ingredient in small molecule medicines. This allowed us to estimate medicine carbon footprints per dose, which we categorized into MCF Ratings, accessible via a searchable web application, MCF Formulary. We performed comparison and sensitivity analyses to validate the ratings, and stratification analyses by therapeutic indication to identify priority areas for emission reduction interventions.
Results
We generated standardized medicine carbon footprints for 2214 products, with 38% rated LOW, 35% MEDIUM, 25% HIGH and 2% VERY HIGH. These products represented 2.2 billion NHS England prescribed doses in January 2023, with a total footprint of 140 000 tonnes CO 2 e, equivalent to the monthly emissions of 940 000 cars. Notably, three antibiotics—amoxicillin, flucloxacillin and penicillin V—contributed 15% of emissions. We estimate that implementing the recommended 20% antibiotic prescription reduction could save 4200 tonnes CO 2 e per month, equivalent to removing 29 000 cars.
Conclusions
Standardized medicine carbon footprints have utility in assessing and addressing the carbon emissions of medicines, and the potential to inform and catalyse changes needed to align better healthcare and net zero commitments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- YewMaker, London, UK.
- SEE Sustainability, Leeming Bar, North Yorkshire, UK.
ORCID-Profile: Haroon Taylor, Matthew Sawyer, Nazneen Rahman
Förderung
- SBRI Healthcare programme
Zitieren
APA
Taylor, H., Mahamdallie, S., Sawyer, M., & Rahman, N. (2024). MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16229
Vancouver
Taylor H, Mahamdallie S, Sawyer M, Rahman N. MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16229
BibTeX
@article{Taylor2024,
author = {Taylor, Haroon and Mahamdallie, Shazia and Sawyer, Matthew and Rahman, Nazneen},
title = {MCF classifier: Estimating, standardizing, and stratifying medicine carbon footprints, at scale},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16229}
}
EUVIMED